Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Q1 2025 Earnings Call Transcript April 30, 2025
Ionis Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $-0.93, expectations were $-1.11.
Operator: Good morning, and welcome to the Ionis First Quarter 2025 Financial Results Conference Call. As a reminder, this call is being recorded. At this time, I would like to turn the call over to Wade Walke, Senior Vice President of Investor Relations, to lead off the call. Please begin.
Wade...
